{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:53:01Z","timestamp":1761058381173,"version":"3.44.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1016\/j.amjmed.2004.12.033","type":"journal-article","created":{"date-parts":[[2005,12,27]],"date-time":"2005-12-27T09:28:19Z","timestamp":1135675699000},"page":"1331-1339","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Managing patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia"],"prefix":"10.1016","volume":"118","author":[{"given":"Mary","family":"McNaughton-Collins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Barry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjmed.2004.12.033_bib1","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0022-5347(17)49698-4","article-title":"The development of human benign prostatic hyperplasia with age","volume":"132","author":"Berry","year":"1984","journal-title":"J Urol"},{"key":"10.1016\/j.amjmed.2004.12.033_bib2","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/S0022-5347(01)66256-6","article-title":"Japanese men have smaller prostate volumes but comparable urinary flow rates relative to American men","volume":"155","author":"Masumori","year":"1996","journal-title":"J Urol"},{"key":"10.1016\/j.amjmed.2004.12.033_bib3","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/S0022-5347(17)32456-4","article-title":"Parameters of prostate volume and shape in a community based population of men 55 to 74 years old","volume":"152","author":"Bosch","year":"1994","journal-title":"J Urol"},{"key":"10.1016\/j.amjmed.2004.12.033_bib4","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0022-5347(17)35640-9","article-title":"Natural history of prostatism","volume":"150","author":"Girman","year":"1993","journal-title":"J Urol"},{"key":"10.1016\/j.amjmed.2004.12.033_bib5","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0090-4295(99)80248-9","article-title":"Natural history of benign prostatic hyperplasia","volume":"46","author":"Bosch","year":"1995","journal-title":"Urology"},{"key":"10.1016\/j.amjmed.2004.12.033_bib6","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0022-5347(01)66461-9","article-title":"Natural history of prostatism","volume":"155","author":"Jacobsen","year":"1996","journal-title":"J Urol"},{"key":"10.1016\/j.amjmed.2004.12.033_bib7","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0022-5347(01)64508-7","article-title":"Natural history of prostatism","volume":"158","author":"Jacobsen","year":"1997","journal-title":"J Urol"},{"key":"10.1016\/j.amjmed.2004.12.033_bib8","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0022-5347(05)68563-1","article-title":"Incidence rates and risk factors for acute urinary retention","volume":"162","author":"Meigs","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.amjmed.2004.12.033_bib9","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1056\/NEJM199802263380901","article-title":"The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia","volume":"338","author":"McConnell","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2004.12.033_bib10","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa030656","article-title":"The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia","volume":"349","author":"McConnell","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2004.12.033_bib11","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1097\/01.ju.0000112918.74410.94","article-title":"Sustained decrease in incidence of acute urinary retention and surgery with finasteride for 6 years in men with benign prostatic hyperplasia","volume":"171","author":"Roehrborn","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.amjmed.2004.12.033_bib12","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1159\/000020189","article-title":"Urinary retention in patients with BPH treated with finasteride or placebo over 4 years. Characterization of patients and ultimate outcomes","volume":"37","author":"Roehrborn","year":"2000","journal-title":"Eur Urol"},{"key":"10.1016\/j.amjmed.2004.12.033_bib13","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0090-4295(01)01155-4","article-title":"Clinical predictors of spontaneous acute urinary retention in men with LUTS and clinical BPH","volume":"58","author":"Roehrborn","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.amjmed.2004.12.033_bib14","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0090-4295(97)00185-4","article-title":"Finasteride significantly reduces acute urinary retention and need for surgery in patients with symptomatic benign prostatic hyperplasia","volume":"49","author":"Andersen","year":"1997","journal-title":"Urology"},{"key":"10.1016\/j.amjmed.2004.12.033_bib15","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1056\/NEJM199501123320202","article-title":"A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia","volume":"332","author":"Wasson","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2004.12.033_bib16","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0022-5347(01)65267-4","article-title":"The natural history of patients with benign prostatic hyperplasia as diagnosed by North American urologists","volume":"157","author":"Barry","year":"1997","journal-title":"J Urol"},{"key":"10.1016\/j.amjmed.2004.12.033_bib17","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0022-5347(05)67909-8","article-title":"Race, ethnicity, and benign prostatic hyperplasia in the health professionals follow-up study","volume":"163","author":"Platz","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.amjmed.2004.12.033_bib18","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S0090-4295(94)80197-5","article-title":"Concordance rates for benign prostatic disease among twins suggest hereditary influence","volume":"44","author":"Partin","year":"1994","journal-title":"Urology"},{"key":"10.1016\/j.amjmed.2004.12.033_bib19","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0022-5347(17)32831-8","article-title":"Genetic susceptibility of benign prostatic hyperplasia","volume":"152","author":"Sanda","year":"1994","journal-title":"J Urol"},{"key":"10.1016\/j.amjmed.2004.12.033_bib20","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S0022-5347(01)65069-9","article-title":"Clinical and biological characteristics of familial benign prostatic hyperplasia","volume":"157","author":"Sanda","year":"1997","journal-title":"J Urol"},{"key":"10.1016\/j.amjmed.2004.12.033_bib21","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/(SICI)1097-0045(19980701)36:2<80::AID-PROS2>3.0.CO;2-I","article-title":"Effect of postnecrotic and alcoholic hepatic cirrhosis on development of benign prostatic hyperplasia","volume":"36","author":"Cetinkaya","year":"1998","journal-title":"Prostate"},{"key":"10.1016\/j.amjmed.2004.12.033_bib22","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1001\/archinte.158.21.2349","article-title":"Physical activity and benign prostatic hyperplasia","volume":"158","author":"Platz","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjmed.2004.12.033_bib23","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S0895-4356(01)00351-1","article-title":"Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men","volume":"54","author":"Meigs","year":"2001","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.amjmed.2004.12.033_bib24","series-title":"Benign Prostatic Hyperplasia (5th International Consultation on BPH)","first-page":"19","article-title":"Epidemiology and natural history","author":"Boyle","year":"2001"},{"key":"10.1016\/j.amjmed.2004.12.033_bib25","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/00000478-198808000-00003","article-title":"Normal histology of the prostate","volume":"12","author":"McNeal","year":"1988","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.amjmed.2004.12.033_bib26","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1136\/bmj.308.6934.929","article-title":"New words for old","volume":"308","author":"Abrams","year":"1994","journal-title":"BMJ"},{"key":"10.1016\/j.amjmed.2004.12.033_bib27","series-title":"Benign Prostatic Hyperplasia (5th International Consultation on BPH)","first-page":"81","article-title":"Regulation of prostate growth","author":"Lee","year":"2001"},{"year":"1994","series-title":"Benign prostatic hyperplasia: diagnosis and treatment. Clinical Practice Guideline, Number 8","author":"McConnell","key":"10.1016\/j.amjmed.2004.12.033_bib28"},{"key":"10.1016\/j.amjmed.2004.12.033_bib29","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/01.ju.0000078083.38675.79","article-title":"American Urological Association guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations","volume":"170","year":"2003","journal-title":"J Urol."},{"key":"10.1016\/j.amjmed.2004.12.033_bib30","first-page":"AS145","article-title":"Measuring disease-specific health status in men with benign prostatic hyperplasia","volume":"33","author":"Barry","year":"1995","journal-title":"Med Care"},{"key":"10.1016\/j.amjmed.2004.12.033_bib31","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/S0022-5347(17)36966-5","article-title":"The American Urological Association symptom index for benign prostatic hyperplasia","volume":"148","author":"Barry","year":"1992","journal-title":"J Urol"},{"key":"10.1016\/j.amjmed.2004.12.033_bib32","series-title":"Benign Prostatic Hyperplasia (5th International Consultation on BPH)","first-page":"203","article-title":"Measuring the symptoms and health impact of benign prostatic hyperplasia and its treatments","author":"Barry","year":"2001"},{"key":"10.1016\/j.amjmed.2004.12.033_bib33","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.urology.2003.08.019","article-title":"Low AUA symptom score independently predicts positive prostate needle biopsy","volume":"63","author":"Porter","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.amjmed.2004.12.033_bib34","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1046\/j.1365-2389.2003.51324.x","article-title":"Prostate cancer detection in older men with and without lower urinary tract symptoms","volume":"51","author":"Blanker","year":"2003","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.amjmed.2004.12.033_bib35","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1046\/j.1464-410x.2000.00659.x","article-title":"Are men with lower urinary tract symptoms at increased risk of prostate cancer? A systematic review and critique of the available evidence","volume":"85","author":"Young","year":"2000","journal-title":"BJU Int"},{"key":"10.1016\/j.amjmed.2004.12.033_bib36","first-page":"47","article-title":"Frequency volume charts","volume":"179","author":"Abrams","year":"1996","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.amjmed.2004.12.033_bib37","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0090-4295(95)96812-1","article-title":"Interexaminer variability of digital rectal examination in detecting prostate cancer","volume":"45","author":"Smith","year":"1995","journal-title":"Urology"},{"key":"10.1016\/j.amjmed.2004.12.033_bib38","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S0090-4295(97)00031-9","article-title":"Correlation between prostate size estimated by digital rectal examination and measured by transrectal ultrasound","volume":"49","author":"Roehrborn","year":"1997","journal-title":"Urology"},{"key":"10.1016\/j.amjmed.2004.12.033_bib39","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S0022-5347(17)35233-3","article-title":"Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer","volume":"151","author":"Catalona","year":"1994","journal-title":"J Urol"},{"key":"10.1016\/j.amjmed.2004.12.033_bib40","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0090-4295(98)00655-4","article-title":"Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia","volume":"53","author":"Roehrborn","year":"1999","journal-title":"Urology"},{"key":"10.1016\/j.amjmed.2004.12.033_bib41","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0090-4295(98)00654-2","article-title":"Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia","volume":"53","author":"Roehrborn","year":"1999","journal-title":"Urology"},{"key":"10.1016\/j.amjmed.2004.12.033_bib42","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0022-5347(05)67962-1","article-title":"Serum prostate specific antigen is a strong predictor of future prostate growth in men with benign prostatic hyperplasia. PROSCAR long term efficacy and safety study","volume":"163","author":"Roehrborn","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.amjmed.2004.12.033_bib43","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0090-4295(94)80119-3","article-title":"In support of pressure-flow studies for evaluating men with lower urinary tract symptoms","volume":"44","author":"Abrams","year":"1994","journal-title":"Urology"},{"key":"10.1016\/j.amjmed.2004.12.033_bib44","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0090-4295(94)80120-7","article-title":"Why pressure-flow studies should be optional and not mandatory studies for evaluating men with benign prostatic hyperplasia","volume":"44","author":"McConnell","year":"1994","journal-title":"Urology"},{"issue":"Suppl 1","key":"10.1016\/j.amjmed.2004.12.033_bib45","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1046\/j.1464-410X.1998.0810s1029.x","article-title":"The pathophysiology of lower urinary tract symptoms in the ageing male population","volume":"81","author":"Lepor","year":"1998","journal-title":"Br J Urol"},{"key":"10.1016\/j.amjmed.2004.12.033_bib46","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/S0022-5347(01)62536-9","article-title":"The impact of medical therapy on bother due to symptoms, quality of life and global outcome, and factors predicting response","volume":"160","author":"Lepor","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.amjmed.2004.12.033_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000019919","article-title":"A meta-analysis on the efficacy and tolerability of alpha1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction","volume":"36","author":"Djavan","year":"1999","journal-title":"Eur Urol"},{"key":"10.1016\/j.amjmed.2004.12.033_bib48","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1001\/jama.283.15.1967","article-title":"Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone","volume":"283","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.amjmed.2004.12.033_bib49","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0090-4295(98)00655-4","article-title":"Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia","volume":"53","author":"Roehrborn","year":"1999","journal-title":"Urology"},{"key":"10.1016\/j.amjmed.2004.12.033_bib50","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0090-4295(02)01905-2","article-title":"Efficacy and safety of a dual inhibitor of 5-alpha reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia","volume":"60","author":"Roehrborn","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.amjmed.2004.12.033_bib51","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0090-4295(98)00184-8","article-title":"Treatment with finasteride preserves usefulness of prostate-specific antigen in the detection of prostate cancer: results of a randomized, double-blind, placebo-controlled clinical trial. Proscar Long-term Efficacy and Safety Study","volume":"52","author":"Andriole","year":"1998","journal-title":"Urology"},{"key":"10.1016\/j.amjmed.2004.12.033_bib52","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1056\/NEJMoa030660","article-title":"The influence of finasteride on the development of prostate cancer","volume":"349","author":"Thompson","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2004.12.033_bib53","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1056\/NEJM200310163491615","article-title":"Prevention of prostate cancer with finasteride","volume":"349","author":"Roehrborn","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2004.12.033_bib54","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJM199608223350801","article-title":"The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia","volume":"335","author":"Lepor","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2004.12.033_bib55","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1001\/jama.280.18.1604","article-title":"Saw palmetto extracts for treatment of benign prostatic hyperplasia","volume":"280","author":"Wilt","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.amjmed.2004.12.033_bib56","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1046\/j.1464-410x.2000.00365.x","article-title":"A systematic review of Cernilton for the treatment of benign prostatic hyperplasia","volume":"85","author":"MacDonald","year":"1999","journal-title":"BJU Int"},{"key":"10.1016\/j.amjmed.2004.12.033_bib57","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/S0002-9343(00)00604-5","article-title":"Pygeum africanum for the treatment of patients with benign prostatic hyperplasia","volume":"109","author":"Ishani","year":"2000","journal-title":"Am J Med"},{"key":"10.1016\/j.amjmed.2004.12.033_bib58","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1046\/j.1464-410x.1999.00026.x","article-title":"Beta-sitosterol for the treatment of benign prostatic hyperplasia","volume":"83","author":"Wilt","year":"1999","journal-title":"BJU Int"},{"key":"10.1016\/j.amjmed.2004.12.033_bib59","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0022-5347(05)67450-2","article-title":"A randomised trial comparing transurethral resection of the prostate, laser therapy and conservative treatment of men with symptoms associated with benign prostatic enlargement","volume":"164","author":"Donovan","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.amjmed.2004.12.033_bib60","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/S0022-5347(05)67143-1","article-title":"Transurethral resection of the prostate among Medicare beneficiaries","volume":"164","author":"Wasson","year":"2000","journal-title":"J Urol"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934305002160?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934305002160?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T08:41:01Z","timestamp":1757580061000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934305002160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":60,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S0002934305002160"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2004.12.033","relation":{},"ISSN":["0002-9343"],"issn-type":[{"type":"print","value":"0002-9343"}],"subject":[],"published":{"date-parts":[[2005,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Managing patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2004.12.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}